Incepta says has capacity to produce 1.2bn vaccines a year | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
July 10, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JULY 10, 2025
Incepta says has capacity to produce 1.2bn vaccines a year

Health

TBS Report
18 March, 2021, 08:10 pm
Last modified: 19 March, 2021, 01:50 pm

Related News

  • US Health Secretary Kennedy guts vaccine advisory committee
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women
  • Study on Bangladeshi children confirms lasting impact of typhoid vaccine

Incepta says has capacity to produce 1.2bn vaccines a year

‘We are the only pharmaceutical company in the country that manufactures vaccines using state-of-the-art technology in compliance with safety protocols’

TBS Report
18 March, 2021, 08:10 pm
Last modified: 19 March, 2021, 01:50 pm
Incepta says has capacity to produce 1.2bn vaccines a year

Incepta Pharmaceuticals authorities say it has the capacity to produce 1.2 billion single doses of bacterial and viral vaccines.

If approved, the company will be able to make Covid-19 vaccine in the country, said the company.

Health Minister Zahid Maleque visited the Incepta vaccine plant on Thursday and the company's Chairman and Managing Director Abdul Muktadir gave journalists a presentation on how to make a vaccine.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Muktadir said they had four German technology filling lines and it is possible for them to produce 400 million single doses of vaccines per line every year.

"So, it is possible to make 1.2 billion doses of vaccines here every year, even if it is Covid-19 vaccine, since we also have a cold chain to store 500 million doses of vaccines," he maintained.

Muktadir claimed that they are the only pharmaceutical company in Bangladesh that manufactures vaccines using state-of-the-art technology in compliance with safety protocols.

"Now if we get a bulk of corona vaccines, we will be able to go into production in two weeks, however, once the master seed is obtained, it can take about 12 weeks to go into production," he said.

In this case, the government cooperation is needed because if the government does not want, it is not possible to bring the vaccine in the country alone, said the Incepta managing director.

While inspecting the factory, Health Minister Zahid Maleque said the government would provide all kinds of assistance to the private sector if the country could produce world-class vaccines as per the Good Manufacturing Practice.

In this case, not only Incepta, the government is willing to help any private organisation, he added.

Incepta has already earned the trust of all by creating multiple life-saving vaccines, the minister noted, saying any opportunity to produce coronavirus vaccine in Bangladesh will actually put the drug company ahead in terms of preparation.

The prime minister herself is sincere about the production of corona vaccine in the country, Zahid said, adding, "We are buying 30 million vaccines from Serum, but it will not meet our needs.

"In this case, the premier has asked me to check the capability of private firms."

The government will buy the vaccine if any local firm can provide it according to the policy of the World Health Organisation, said the minister.

"If Incepta can provide us with a quality vaccine, we will consider it. We have some limitations, but we are working on them," he added.

Meanwhile, Major General Mahbubur Rahman, director general of the Department of Drug Administration, said, "We have already written to the World Health

Organization and Oxford- AstraZeneca for vaccine bulk or master seed for vaccine production in the country.

"I hope they will tell us something positive. We are also in discussion with others."

Incepta says the company's vaccine production capability is not being fully utilised now. About half its capacity (628 million) is being used.

Incepta is the first life-saving international standard vaccine manufacturer in Bangladesh. Its vaccine factory in Savar officially started its journey in June 2011.

The company is producing and marketing more than 10 vaccines including rabies, rabies-IG, hepatitis B, typhoid, tetanus, tetanus-IG, measles-rubella, antivenom, flu and meningitis.

Incepta has been making these vaccines for the country as well as exporting them to 12 countries of the world.
 

Bangladesh / Top News

Incepta / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Mohammad Minhaj Uddin/TBS
    SSC, equivalent results: Pass rate drops to 68.45%, GPA-5 also declines
  • In terms of stream of education, girls maintained their excellence as well. Photo: TBS
    SSC 2025: Girls dominate boys by over 5%
  • BBC reported that the phone call took place on 18 July last year while Hasina was at Ganabhaban in Dhaka. Photo: TBS
    How BBC verified Hasina’s leaked audio ordering deadly crackdown during July Uprising

MOST VIEWED

  • Graphics: TBS
    BB raises startup fund limit, drops upper age barrier
  • Workers pack undergarments at the packing section of a garment factory in Ashulia, on the outskirts of Dhaka, Bangladesh, April 19, 2025. Photo: REUTERS/Fatima Tuj Johora
    After US tariffs, jobs hang by a thread in Bangladesh's garments sector
  • Global Islami Bank rectifies 2023 figures, reports Tk2,259cr loss instead of Tk128cr profit
    Global Islami Bank rectifies 2023 figures, reports Tk2,259cr loss instead of Tk128cr profit
  • Bangladesh Bank Governor Ahsan H Mansur. TBS Sketch
    Audit reports of most banks contain cooked up data: BB governor
  • File photo of containers at Chattogram port/TBS
    US buyers push Bangladeshi exporters to share extra tariff costs
  • CA orders law enforcers to complete all election preparations by December
    CA orders law enforcers to complete all election preparations by December

Related News

  • US Health Secretary Kennedy guts vaccine advisory committee
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women
  • Study on Bangladeshi children confirms lasting impact of typhoid vaccine

Features

Women are forced to fish in saline waters every day, risking their health to provide for their families. Photo: TBS

How Mongla’s women are bearing the brunt of rising salinity

18h | Panorama
Dr Mostafa Abid Khan. Sketch: TBS

Actual impact will depend on how US retailers respond: Mostafa Abid Khan

2d | Economy
Thousands gather to form Bangla Blockade in mass show of support. Photo: TBS

Rebranding rebellion: Why ‘Bangla Blockade’ struck a chord

2d | Panorama
The Mitsubishi Xpander is built with families in mind, ready to handle the daily carpool, grocery runs, weekend getaways, and everything in between. PHOTO: Akif Hamid

Now made-in-Bangladesh: 2025 Mitsubishi Xpander

3d | Wheels

More Videos from TBS

How S Alam’s Global Islami Bank cooked Tk2,259cr loss into Tk128cr profit

How S Alam’s Global Islami Bank cooked Tk2,259cr loss into Tk128cr profit

13m | TBS Insight
Trump has been nominated for the Nobel Peace Prize before

Trump has been nominated for the Nobel Peace Prize before

1h | TBS World
Trump threatens to impose 50 percent tariffs on Brazil

Trump threatens to impose 50 percent tariffs on Brazil

3h | TBS World
Can India stop water flow to Pakistan?

Can India stop water flow to Pakistan?

4h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net